ZeOmega, a US-based software company whose principal product is Jiva, a population healthcare management platform, has closed a $21.5m growth equity financing round led by private equity fund Bregal Sagemount, with participation from existing investors BlueCross BlueShield Venture Partners, a corporate venture fund sponsored by the Blue Cross and Blue Shield Association of healthcare companies, and venture capital firm Sandbox Industries.
Phil Yates, founding partner at Bregal Sagemount, joins the company’s board of directors.
Previously, BlueCross BlueShield Venture Partners and Sandbox Industries backed ZeOmega’s undisclosed series A funding in August 2011. Zeomega was founded in 2001, –
Sam Rangaswamy, founder and chief executive officer of ZeOmega, said: “We’re delighted to partner with Bregal Sagemount. Their team has demonstrated an in-depth understanding of the intricacies of today’s healthcare IT market and we feel confident they will be able to help us expand our footprint in the industry. It is likewise gratifying that BlueCross BlueShield Venture Partners and Sandbox Industries have continued their support, validating the results and value delivered as a result of the earlier round of funding.”